Investigating protein levels to improve precision medicine
NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) - TASK AREAS 4 AND 5 - 2024 TASK ORDER
This study is looking at how proteins in your blood relate to health and disease, with the goal of finding better ways to treat conditions by understanding how these proteins work together, so patients can receive more personalized care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11212416 on NIH RePORTER |
What this research studies
This research focuses on generating high-quality proteomics data to better understand the relationship between protein levels and health conditions. By utilizing advanced techniques like mass spectrometry and capture agents, the study aims to profile a wide range of proteins that may be crucial for identifying disease phenotypes and therapeutic targets. Patients may benefit from insights gained about how proteins function and interact in the body, which could lead to more personalized treatment options. The research will involve analyzing blood plasma samples to uncover valuable information about protein dynamics.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with cardiovascular diseases or those at risk for such conditions who are willing to provide blood samples for analysis.
Not a fit: Patients with conditions unrelated to protein dynamics or those who are not willing to participate in blood sample collection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatments for cardiovascular diseases and other conditions by providing deeper insights into protein functions.
How similar studies have performed: Previous research using proteomics has shown promise in identifying biomarkers for various diseases, indicating that this approach has potential for success.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Economy, Irene — Stanford University
- Study coordinator: Economy, Irene
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.